Antidiabetic Medicines

Product Details:

Rybelsus 3 mg Tablet contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus—especially when metformin is inappropriate or insufficient. It helps lower blood glucose by enhancing glucose-dependent insulin secretion and suppressing glucagon release, and may also induce weight loss effects. The typical initiation dose is 3 mg once daily (for one month), rising to 7 mg and eventually 14 mg to optimize glycemic control. Taken orally on an empty stomach with water, patients must wait at least 30 minutes before eating or taking other medications. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Serious but rare risks include pancreatitis, hypoglycemia (when combined with insulin or sulfonylureas), acute kidney injury, and a potential risk for thyroid C-cell tumors—making it contraindicated for those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Product Details:

Rybelsus 7 mg Tablet contains semaglutide, a once-daily oral GLP‑1 receptor agonist used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise. It's typically prescribed after a one-month introductory course of 3 mg, with a maintenance dose of 7 mg once daily—possibly escalating to 14 mg for enhanced effect. Semaglutide works by enhancing insulin release, suppressing glucagon during high blood-sugar states, and slowing gastric emptying to help lower both fasting and postprandial glucose levels, while also aiding weight loss. Take it on an empty stomach with a small sip of water and wait at least 30 minutes before eating—this ensures proper absorption and effectiveness.

Product Details:

Rybelsus 14 mg Tablet is a once-daily oral formulation of semaglutide, a GLP‑1 receptor agonist used in adults with type 2 diabetes as an adjunct to diet and exercise for better blood sugar control. The 14 mg dose is typically reached after stepwise escalation from 3 mg, and offers enhanced effectiveness—clinical studies show an average HbA₁c reduction of approximately 1.3% at this dose (compared to 1.0% with 7 mg) 

Product Details:

Phage 500mg Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control blood sugar levels and thus prevents serious complications of diabetes. It is also used to treat a menstruation-related disorder known as polycystic ovary syndrome (PCOS) in women

Product Details:

Metfoxia is a prescription oral antidiabetic medication, containing metformin hydrochloride 500 mg, part of the biguanide class. It helps improve blood sugar control in adults and children (10 years and above) with type 2 diabetes by reducing glucose production in the liver, improving intestinal absorption, and enhancing insulin sensitivity. Used alongside diet and exercise, it's often the first-line treatment when lifestyle measures alone are insufficient.

Product Details:

Vildasmart M is a fixed-dose combination tablet containing Vildagliptin 50 mg, a DPP‑4 inhibitor, and Metformin Hydrochloride 1000 mg, a biguanide antihyperglycemic—developed to improve glycemic control in adult patients with type 2 diabetes when diet, exercise, and either agent alone are inadequate. Vildagliptin enhances insulin secretion and suppresses glucagon by preserving incretin hormones, while Metformin lowers hepatic glucose production and increases peripheral insulin sensitivity 

Product Details:

Vildasmart SR 100 mg Tablet contains vildagliptin in a sustained-release (SR) formulation designed for once-daily dosing. It helps manage type 2 diabetes by inhibiting DPP‑4, enhancing incretin hormones to boost insulin secretion, and suppressing glucagon levels—resulting in better fasting and post-meal blood sugar control. The SR matrix ensures steady drug release over 24 hours, offering similar efficacy to the standard 50 mg twice-daily dose while improving convenience and compliance

Product Details:

Vildasmart 50 mg Tablet contains vildagliptin, a DPP‑4 inhibitor used to help manage type 2 diabetes mellitus when diet and exercise alone are inadequate. By preventing the breakdown of incretin hormones (GLP‑1 and GIP), it promotes glucose-dependent insulin secretion and suppresses glucagon release—leading to better control of both fasting and post-meal blood sugar levels with a low risk of hypoglycemia and no associated weight gain 

Product Details:

Jalra 50 mg Tablet contains the active ingredient vildagliptin, a dipeptidyl peptidase‑4 (DPP‑4) inhibitor used to manage type 2 diabetes in adults—in combination with diet and exercise—either alone or alongside medications like metformin, sulfonylureas, thiazolidinediones, or insulin when blood sugar remains inadequately controlled